Research News
 
April 3, 2020
 

Click the hyperlinks below to view:

Click here for a comprehensive listing of NIH and other grant deadlines.

Important: Please submit your proposal via Kuali Coeus (KC). The KC proposal should include the proposal budget, budget justification, abstract (scope of work), and RFA guidelines. The KC Proposal should be routed to the KSOM Research Administration office (KAM 400) at least 5 business days in advance of the grant deadline, and the full application to Department of Contracts and Grants via KC at least 3 business days in advance of the deadline, to ensure that there is adequate time to review and process your application. https://research.usc.edu/files/2014/09/Step-by-Step1.pdf

 
 
Funding Opportunity: AHA Rapid Response Grant COVID-19 and Its Cardiovascular Impact, Apr 6

The American Heart Association (AHA) invites cardiovascular-focused applications that will contribute to understanding the cardiovascular and cerebrovascular pathogenesis, diagnosis, prevention, clinical manifestations, clinical management (including critical care management) and social behaviors which can lead to dissemination, containment, and complications of COVID-19. Because of the urgency of this issue, innovative, highly impactful short-term proposals (9-12 months), which can show progress within the period of this award, are sought.
Due Date: 3PM PST on April 6, 2020

Link to Award    
back to top 
 
Funding Opportunity: California Institute for Regenerative Medicine (CIRM) Special Call for COVID-19 Projects

Partnership Opportunities in Support of Discovery, Translational and Clinical Trial Stage Activities
The mission of California Institute for Regenerative Medicine (CIRM) is to accelerate stem cell treatments to patients with unmet medical needs. Given the growing surge of COVID-19 cases in California and throughout the world, CIRM is issuing this special announcement to support promising discovery, preclinical and clinical trial stage projects that could quickly advance treatments to COVID-19 patients in need. CIRM is utilizing its established partnering opportunities across Discovery (DISC2), Translational (TRAN1), and Clinical (CLIN1,CLIN2) stages to provide support for COVID-19 related projects. This Program Announcement will describe the unique and applicable requirements for supporting COVID-19 projects but will refer to the specific program stage announcements for additional details.
Note: First due date is 2:00 pm (PDT/PST) on April 7, 2020 and approximately every two weeks thereafter

Link to Award    
back to top 
 
Funding Opportunity: NIST Manufacturing USA National Emergency Assistance Program

Collectively, Manufacturing USA institutes have over 2,000 member institutions including small manufacturers, two-thirds of Fortune 50 U.S. manufacturers, and nearly every top ranked research and engineering university in the United States. Its network of research and development institutes that engage with these industry-led institutions positions it well to distribute high-impact funding into existing efforts in the manufacturing sector to both stimulate the US economy and to support efforts to respond to the COVID-19 pandemic and other public health crises. Projects may include medical countermeasures; non-medical countermeasures; leveraging institute capabilities to strengthen state and community resilience; grants to companies and technical support to accelerate productions of critical materials, equipment, and supplies; creation of additional production facilities; technology roadmapping for pandemic response and recovery; reshoring the manufacture of critical conventional drugs and ensuring supply chain for critical materials related to pandemic response; or workforce development and training for a skilled advanced manufacturing workforce.
Note: Applications for funding pursuant to this NOFO will be reviewed and considered on a rolling basis as they are received.

Link to Award    
back to top 
 
Funding Opportunity: Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)

NIAID is issuing this Notice of Special Interest (NOSI) to highlight the need for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). NIAID is particularly interested in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against SARS-CoV-2/COVID-19. Applications in response to this NOSI must be submitted using the following targeted funding opportunity: PA-20-135; Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional), which is intended to provide funds for NIH grantees applying to expand the scope of their active grant.
Note: Applications will be accepted on a rolling basis 03/25/2020 from 03/25/2021 through 5:00 PM local time of the applicant organization.

Link to Award    
back to top 
 
Funding Opportunity: Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus

A better understanding of the host response, associated disease, and short- and long-term clinical outcomes of individuals infected with SARS-CoV-2. For NHGRI grantees only (including those with a current extension of funds or a no cost extension), we encourage the submission of applications for Competitive Revisions to support genomic research on SARS-CoV-2 and COVID-19 disease. Of particular interest are genomic studies utilizing generalized approaches that take advantage of human research or model systems to study the consequences of SARS-CoV-2 infection. Supported research is expected to guide and inform future efforts to diagnose, prevent, mitigate, or treat this viral infection.
Funds may be used for the collection of samples from human cohorts of individuals with COVID-19 symptoms or evidence of SARS-CoV-2 infection or controls, and/or development of novel model systems to expose animals and cells to SARS-CoV-2.
Note: Applications will be accepted on a rolling basis from April 1 through May 15, 2020 by 5:00 PM local time of the applicant organization.

Link to Award    
back to top 
 
Funding Opportunity: Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional) PA-18-935

The National Institutes of Health (NIH) hereby notify Principal Investigators holding specific types of NIH research grants, listed in the full Funding Opportunity Announcement (FOA) that funds may be available for competitive revisions to meet immediate needs to help address a specific public health crisis in a timely manner, but that were unforeseen when the new or renewal application or grant progress report for non-competing continuation support was submitted. Applications for Urgent Competitive Revisions will be routed directly to the NIH awarding component listed on the NoA of the most recent parent award.
Only applications submitted in response to an Urgent Guide Notice published by an IC will be allowed to apply to this FOA.
Earliest start dates may vary by awarding IC. See the Urgent Guide Notices for any applicable Application Due Dates.

Link to Award    
back to top 
 
Funding Opportunity: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) PA-18-591

The National Institutes of Health (NIH) hereby notify Program Directors/Principal Investigators (PD(s)/PI(s)) holding specific types of NIH research grants listed in the full Funding Opportunity Announcement (FOA) that funds may be available for administrative supplements to meet increased costs that are within the scope of the approved award, but were unforeseen when the new or renewal application or grant progress report for non-competing continuation support was submitted.
Due dates may vary by awarding IC. See the awarding IC's web site for any applicable Application Due Dates.

Link to Award    
back to top 
 
Information for NIH Applicants and Recipients of NIH Funding

NIH Guidance, FAQs, and Funding Opportunities Specific to COVID-19

https://grants.nih.gov/policy/natural-disasters/corona-virus.htm

   
back to top 
 
NSF Implementation of OMB Memo M-20-17: Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus due to Loss of Operations

The National Science Foundation has issued Important Notice No 146 to the Community Regarding COVID-19. NSF has also issued additional guidance on NSF's implementation of the Office of Management and Budget (OMB) Memorandum (M-20-17), entitled, Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations. NSF has implemented flexibilities authorized by OMB from specific administrative, financial management and audit requirements contained in 2 CFR Part 200, Uniform Administrative Requirements, Cost Principles and Audit Requirements for Federal Awards without compromising accountability requirements.

Any questions about the policies described in the NSF Guidance should be directed to policy@nsf.gov. Questions specific to a particular award should be directed to the cognizant NSF Program Officer. NSF is working to update existing FAQs and other resources to reflect NSF's new guidance and will keep you informed on our website at: nsf.gov/coronavirus.

   
back to top 
 
 
Research Supplements to Promote Diversity in Health-Related Research, Sep 8

The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) hereby notify Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) holding specific types of research grants (activity codes listed above) that funds are available for administrative supplements to improve the diversity of the research workforce by recruiting and supporting students, postdoctorates, and eligible investigators from groups that have been shown to be underrepresented in health-related research.

Last Deadline: September 08, 2021

Link to Website    
back to top 
 
USC Conflict of Interest training and disclosure, Oct 31

Please be advised that faculty who wish to submit proposals to HHS agencies (such as NIH) must complete their USC Conflict of Interest training and disclosure as required by federal regulation. This requirement includes new grant submissions, competing renewals and non-competing continuations (progress reports). Click on "diSClose" to submit the on-line disclosure, in the following link.

Last Deadline: October 31, 2030

Disclose    
back to top 
 
 
SC CTSI Team Building Opportunity, Jun 30

The Southern California Clinical and Translational Science Institute is seeking applications for team building activities of up to $3,000 each from small research teams.  This mechanism is intended to provide rapid funding for activities that promote the SC CTSI goal of assembling new multidisciplinary or transdisciplinary teams focused on clinical and community research, particularly those that are grounded in the team science principles (https://sc-ctsi.org/training-education/team-science-training) principles.

SC CTSI - Team Building Voucher
Up to $3,000


Apply by: Rolling Application

PIs must submit their application as a Limited Submission through the Office of Research Application Portal: https://app.wizehive.com/webform/USCgrants by June 30, 2020.

Materials to be submitted include: (1) a Single Page Proposal Summary (0.5" margins; single-spaced; font type: Arial, Helvetica, or Georgia typeface; font size: 11 pt.); and (2) a CV that is 5 pages maximum.

Website  Details 2  
back to top 
 
 

The following funding opportunities are Institutionally Limited. USC may submit only a limited number of proposals to the sponsor for that particular grant. If you are interested in any of these funding opportunities, your proposal must be submitted through the KSOM Office of Research Advancement. Final selection of applicant is decided by the Office of the Vice President of Research.

Important!: For any limited submission opportunity that is not advertised by the USC Office of Research, please inform Silvia da Costa at sdacosta@usc.edu or Mike Yarsky at yarsky@research.usc.edu as soon as possible to give their office time to announce and review applications.

 
Provost New Strategic Directions for Research Award, Apr 20

The Provost New Strategic Directions for Research Award (PNSDRA) Program will support innovative, interdisciplinary, collaborative research that involves faculty groups from multiple USC schools. The goal of this highly competitive funding opportunity is to identify as-yet undeveloped areas of USC interdisciplinary strengths that present opportunities for cross-school collaborations, targeting research problems that have high intellectual value and impact, and are externally fundable so they can be sustained and scaled up.

Last Deadline: April 20, 2020

Link to Award    
back to top 
 
The Center at Sierra Health Foundation - Asthma Mitigation Project, Apr 28

The Asthma Preventive Services Project is funded by the California Department of Health Care Services as one-time funding to support local health departments, medical providers and community-based organizations to offer asthma home visiting services, including education and environmental trigger mitigation. Awarded funds will support environmental mitigation, education and disease-management services to individuals with poorly controlled asthma. Activities supported by this funding opportunity must be related to environmental mitigation, education and disease-management services for individuals with poorly controlled asthma, and must be focused on the following three outcomes: 1. Improvement in asthma self-management 2. Decreased exposure to environmental triggers 3. Improved asthma outcomes.
Please note this solicitation is on a first-come, first-served basis

Last Deadline: April 28, 2020

Link to Award    
back to top 
 
Brain Research Foundation Scientific Innovations Award, May 1

The objective of the SIA is to support projects that may be too innovative and speculative for traditional funding sources but still have a high likelihood of producing important findings. It is expected that investigations supported by these grants will yield high impact findings and result in major grant applications and significant publications in high impact journals.

Last Deadline: May 01, 2020

Link to Award    
back to top 
 
RFA-AR-21-003 - NIAMS Skin Biology and Diseases Resource-based Centers (P30 - Clinical Trial Not Allowed), May 8

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) requests applications for the NIAMS Resource-based Centers Program (P30) for research areas within its mission in skin biology and diseases research. The Resource-based Centers will provide critical research infrastructure, shared facilities, services, and/or resources to groups of investigators conducting research on skin biology and diseases, enabling them to conduct their independently-funded individual and/or collaborative research projects more efficiently and/or more effectively, with the broad overall goal of accelerating, enriching, and enhancing the effectiveness of ongoing basic, translational, and clinical research and promoting new research within the NIAMS mission.

Last Deadline: May 08, 2020

Link to Award    
back to top 
 
NSF 20-554 - ADVANCE: Organizational Change for Gender Equity in STEM Academic Professions (ADVANCE), May 15

The NSF ADVANCE program goal is to broaden the implementation of evidence-based systemic change strategies that promote equity for STEM2 faculty in academic workplaces and the academic profession. The NSF ADVANCE program provides grants to enhance the systemic factors that support equity and inclusion and to mitigate the systemic factors that create inequities in the academic profession and workplaces. All NSF ADVANCE proposals are expected to use intersectional approaches in the design of systemic change strategies in recognition that gender, race and ethnicity do not exist in isolation from each other and from other categories of social identity. The solicitation includes four funding tracks: Institutional Transformation (IT), Adaptation, Partnership, and Catalyst, in support of the NSF ADVANCE program goal to broaden the implementation of systemic strategies that promote equity for STEM faculty in academic workplaces and the academic profession.

Last Deadline: May 15, 2020

Link to Award    
back to top 
 
RFA-HD-21-010 - Population Dynamics Centers Research Infrastructure Program FY 2021 (P2C Clinical Trial Not Allowed), May 15

The goal of this funding opportunity announcement (FOA) is to advance the field of population dynamics research by increasing research impact, innovation, and productivity; developing junior scientists; and maximizing the efficiency of research support.
Applications must include a minimum of two research infrastructure cores, a mandatory Administrative Core plus a Development Core and/or one or more Scientific/Technical Cores. The Development Core is meant to develop junior scientists and advance new scientific research within the center. A Scientific/Technical Core is meant to provide scientific and/or technical services and/or resources to center researchers in order to enhance their research capabilities.

Last Deadline: May 15, 2020

Link to Award    
back to top 
 
RFA-AR-21-004 - NIAMS Resource-based Centers for Bone, Muscle and Orthopaedic Research (P30 - Clinical Trial Not Allowed), May 15

The NIAMS requests applications for the NIAMS Resource-based Centers Program (P30) to provide critical research infrastructure, shared facilities, services, and resources to groups of investigators conducting research on bone, muscle and orthopaedic biology and diseases, with the broad overall goal of accelerating, enriching, and enhancing the effectiveness of ongoing basic, translational, and clinical research and promoting new research on bone, muscle and orthopaedics within the NIAMS mission. The Centers could potentially facilitate projects in many areas of bone, muscle, orthopaedics, including musculoskeletal tissue engineering and regenerative medicine research on muscles, skeleton, cartilage, and other connective tissues such as tendon and ligament. Key public health problems addressed by this research include, but are not limited to, osteoporosis, osteoarthritis, orthopaedic disorders, and muscle diseases including muscular dystrophies.

Last Deadline: May 15, 2020

Link to Award    
back to top 
 
 
Harrington Scholar-Innovator Award, Apr 10

Harrington Discovery Institute is issuing a call for proposals for the flagship Harrington Scholar-Innovator program to recognize physician-scientists whose research has the potential to advance the standard of care. Novel treatment approaches for all diseases are eligible. We seek proposals that demonstrate creativity, innovation, and potential for clinical impact.
LOI Submission Deadline extended to: April 10, 2020
Full Proposal Deadline for those invited: May 22, 2020
For more information, visit HarringtonDiscovery.org/grant.
To submit an LOI, go to HDI's grant system and create an account.
**If you would like to submit an LOI and it is difficult for you to access the online system prior to the deadline, email Rebecca.Haag@HarringtonDiscovery.org and she will send you the LOI fields in a Word document.

Last Deadline: April 10, 2020

Link to Award    
back to top 
 
William T. Grant Scholars Program, Apr 15

The William T. Grant Scholars Program supports career development for promising early-career researchers. We recognize that early career researchers are rarely given incentives or support to take measured risks in their work, so this award includes a mentoring component, as well as a supportive academic community. Awards are based on applicants' potential to become influential researchers, as well as their plans to expand their expertise in new and significant ways. Proposed research plans must address questions that are relevant to policy and practice in the Foundation's focus areas:
-Reducing Inequality
-Improving the Use of Research Evidence
For more information on applicant eligibility, please see the Link to Award below.

Submission and review process: This opportunity is institutionally limited accepting only one proposal per school (e.g. one for KSOM). If you are interested in applying, please submit your CV and/or NIH Biosketch no later than March 31, 2020 via email to Jessica Madrid Hurtado at jessica.madridhurtado@med.usc.edu.

Last Deadline: April 15, 2020

Link to Award    
back to top 
 
West Coast Consortium for Technology & Innovation in Pediatrics - 2020 Catalyzing Pediatric Innovation (CPI) Grant, May 1

Supported through a pediatric device consortia grant from the FDA, the West Coast Consortium for Technology & Innovation in Pediatrics (CTIP) is pleased to provide grants to support the advancement of innovations in pediatric technology and devices. Funds will be granted to develop pediatric innovation from ideation through commercialization. Funds are available to support the achievement of milestones on the path to development of pediatric innovation in devices and technology.
Deadline for LOI: May 1, 2020

Last Deadline: May 01, 2020

Link to Award    
back to top 
 
NIAID Physician-Scientist Pathway to Independence Award, May 8

The purpose of the NIAID Physician-Scientist Pathway to Independence Award (K99/R00) program is to increase and maintain a strong cohort of new and talented independent physician-scientists. This program is designed to facilitate a timely transition of outstanding postdoctoral researchers with a clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. The program will provide independent NIAID research support during this transition to help awardees launch competitive, independent research careers in biomedical fields and thereby help to address the national physician-scientist workforce shortage.

Last Deadline: May 08, 2020

Link to Website    
back to top 
 
Notice of Special Interest (NOSI): Competitive Revisions for Firearms Injury and Mortality Prevention Research, May 15

This Notice solicits competitive revision applications to support the expansion of existing R01 and R21 programs well poised to expand their focus to include firearms research as described below. Revision applications can support a significant expansion of the scope and research protocol approved and funded for the "parent" award on which the revision application is based.
Research encouraged by this NOSI is consistent with a broad public health approach to firearm injury and mortality prevention including identifying those at risk for firearm injury and mortality (both victims and perpetrators), development and evaluation of theoretically-grounded programs to prevent firearm injury and mortality, and implementation research to explore the barriers and facilitators to support broader adoption of effective programs.

Last Deadline: May 15, 2020

Link to Award    
back to top 
 
ADDF-Harrington Scholar Award, May 18

The Alzheimer's Drug Discovery Foundation (ADDF) and Harrington Discovery Institute (HDI) have partnered to accelerate the translation of academic discoveries into medicines for treating, preventing, or curing patients with Alzheimer's disease and related dementias. Of particular interest are targets related to proteostasis and neurovascular health. Researchers working on drug development programs that are relevant to, but not presently focused on, the Alzheimer's field are encouraged to apply.
LOI Submission Deadline extended to: May 18, 2020
Full Proposal Deadline for those invited: August 10,2020
For more information, visit HarringtonDiscovery.org/ADDF.
To submit an online application, go to ADDF's funding system and create an account.
Scientific questions about your proposal? Contact Meriel Owen, PhD, Alzheimer's Drug Discovery Foundation at mowen@alzdiscovery.org.

Last Deadline: May 18, 2020

Link to Award    
back to top 
 
The Mark Foundation for Cancer Research - Emerging Leader Award, Jun 4

The Mark Foundation Emerging Leader Awards support innovative research from the next generation of leaders in cancer research. These grants are awarded to outstanding early career investigators to support high-impact, high-risk projects that are distinct from their current research portfolio.

Last Deadline: June 04, 2020

Link to Award    
back to top 
 
NSF-20-525: Faculty Early Career Development Program (CAREER), Jul 27

The Faculty Early Career Development (CAREER) Program is a Foundation-wide activity that offers the National Science Foundation's most prestigious awards in support of early-career faculty who have the potential to serve as academic role models in research and education and to lead advances in the mission of their department or organization. Each year NSF selects nominees for the Presidential Early Career Awards for Scientists and Engineers (PECASE) from among the most meritorious recent CAREER awardees. Selection for this award is based on two important criteria: 1) innovative research at the frontiers of science and technology that is relevant to the mission of NSF, and 2) community service demonstrated through scientific leadership, education, or community outreach.

Last Deadline: July 27, 2020

Link to Award    
back to top 
 
USAMRMC FY18-FY22 Broad Agency Announcement for Extramural Medical Research, Sep 30

Description:
The USAMRMC mission is to provide solutions to medical problems of importance to the American Service member at home and abroad, as well as to the general public at large. The scope of this effort and the priorities attached to specific projects are influenced by changes in military and civilian medical science and technology, operational requirements, military threat assessments, and national defense strategies. Extramural research and development programs play a vital role in the fulfillment of the objectives established by the USAMRMC. Projects funded under this BAA must be for basic and applied research to support scientific study and experimentation directed toward advancing the state of the art or increasing knowledge or understanding rather than focusing on development of a specific system or hardware solution. Research and development funded through this BAA are intended and expected to benefit and inform both military and civilian medical practice and knowledge.

Last Deadline: September 30, 2022

Announcement Link  Flyer  
back to top 
 

A publication of Keck Office of Research, the  Keck Research Communications: Funding Opportunities is designed to serve the research community. We actively solicit your input. Please contact the editors with items for publication

Editor: Jessica Madrid Hurtado
Layout & Deployment: Cancer Research Informatics Core

Thomas A. Buchanan, M.D., Vice Dean for Research
Janet A. Stoeckert, M.A., Director of Research Administration